Insider Shareholders with Direct Ownership of Staar Surgical CO (STAA)
This section provides a comprehensive overview of the insiders with direct ownership of Staar Surgical CO (STAA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
STAAR SURGICAL CO Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Broadwood Partners, L.P.
> 10% Shareholder |
2,276,424 | 2,363,172 | 8,592,007 $249 Million | 64 |
Oct 01, 2021
Reduced 0.83%
|
|
Caren L Mason
President & CEO |
560,402 | 452,000 | 152,415 $4.42 Million | 25 |
Jun 06, 2022
Added 3.9%
|
|
Hans Martin Blickensdoerfer
Sr. VP, Comm. Ops, China |
184,013 | 228,853 | 83,110 $2.41 Million | 16 |
Mar 07, 2022
Added 6.64%
|
|
Thomas G Frinzi
President & CEO |
90,417 | 11,240 | 81,294 $2.36 Million | 5 |
Jan 03, 2024
Reduced 11.67%
|
|
Patrick F. Williams
Chief Financial Officer |
48,732 | 13,499 | 45,475 $1.32 Million | 15 |
Mar 07, 2024
Added 5.44%
|
|
Samuel J Gesten
Chief Legal Officer |
50,197 | 47,717 | 43,665 $1.27 Million | 11 |
Mar 20, 2023
Reduced 2.0%
|
|
James E Francese
Sr. VP, Comm. Ops., NA, APAC |
105,857 | 114,580 | 42,660 $1.24 Million | 22 |
Mar 20, 2023
Reduced 1.83%
|
|
Scott D Barnes
Chief Medical Officer |
70,635 | 49,523 | 41,502 $1.2 Million | 17 |
Mar 20, 2023
Reduced 2.15%
|
|
Robert Studholme
Senior VP, Operations |
10,568 | 0 | 31,980 $927,100 | 2 |
Mar 10, 2023
Added 21.69%
|
|
Keith Holliday
Chief Technology Officer |
85,889 | 77,064 | 28,157 $816,271 | 16 |
Mar 20, 2023
Reduced 3.12%
|
|
Nathaniel Sisitsky
General Counsel |
21,935 | 0 | 21,935 $635,895 | 1 |
Dec 11, 2023
Added 50.0%
|
|
Warren Foust
Chief Operating Officer |
20,331 | 2,418 | 17,913 $519,297 | 2 |
May 08, 2024
Reduced 11.89%
|
|
Jon K. Hayashida
VP, Global Clinical, Medical |
54,719 | 49,212 | 16,301 $472,565 | 7 |
May 10, 2021
Reduced 39.76%
|
| 15,352 | 0 | 15,352 $445,054 | 6 |
Jun 20, 2024
Added 22.62%
|
|
| 29,676 | 20,328 | 15,156 $439,372 | 15 |
Jun 20, 2024
Added 12.9%
|
|
|
Magda Michna
Chief Clinical, Regulatory, |
14,047 | 1,670 | 12,377 $358,809 | 2 |
May 08, 2024
Reduced 11.89%
|
|
Gilbert H Kliman
Director |
7,876 | 0 | 10,457 $303,148 | 5 |
Dec 01, 2023
Added 3.38%
|
|
Graydon C. Hansen
Sr. VP, Global Operations |
38,644 | 50,396 | 8,847 $256,474 | 6 |
May 12, 2021
Reduced 38.47%
|
| 5,099 | 0 | 5,099 $147,820 | 3 |
Jun 20, 2024
Added 30.56%
|
|
| 4,571 | 0 | 4,571 $132,513 | 3 |
Jun 20, 2024
Added 32.93%
|
|
| 4,208 | 0 | 4,208 $121,989 | 3 |
Aug 12, 2024
Added 23.81%
|
|
| 3,543 | 0 | 3,543 $102,711 | 2 |
Jun 20, 2024
Added 38.78%
|
|
|
Lou Silverman
Director |
30,728 | 53,917 | 2,924 $84,766 | 4 |
Aug 10, 2021
Reduced 77.24%
|
|
K Peony Yu
Director |
2,786 | 0 | 2,786 $80,766 | 4 |
Jun 15, 2023
Added 38.02%
|
|
John C Moore
Director |
16,206 | 16,206 | 2,117 $61,371 | 2 |
Nov 09, 2020
Reduced 88.45%
|